SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001654954-23-004104
Filing Date
2023-03-31
Accepted
2023-03-31 16:06:14
Documents
1
Group Members
HALE BIOPHARMA VENTURES LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D/A drma_sc13da.htm SC 13D/A 46977
  Complete submission text file 0001654954-23-004104.txt   48397
Mailing Address 1042-B NORTH EL CAMINO REAL, SUITE 430 ENCINITAS CA 92024
Business Address
HALE DAVID F (Filed by) CIK: 0001024004 (see all company filings)

State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Subject) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92822 | Film No.: 23787584
SIC: 2834 Pharmaceutical Preparations